No approved treatments are currently available for acute tricyclic antidepressant poisoning. An additional 1 compound holds orphan drug designation.

Orphan Drug Designations

While no drugs are FDA-approved specifically for acute tricyclic antidepressant poisoning, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.

The following drugs have received orphan drug designation from the FDA for acute tricyclic antidepressant poisoning. Orphan designation reflects regulatory interest and does not indicate approval for treatment.

Estimated prevalence: Unknown (Unknown prevalence).

No clinical trials have been registered for acute tricyclic antidepressant poisoning.

4 publications have been identified in PubMed for acute tricyclic antidepressant poisoning. Research spans Review / Meta-Analysis (50%) and Epidemiology / Natural History (50%).

Recent Publications

• Pereira M (2026). [PMID: 41378830](https://pubmed.ncbi.nlm.nih.gov/41378830/). *Clinical toxicology (Philadelphia, Pa.)*. [Epidemiology / Natural History]

• Maruniak S (2025). [PMID: 40263908](https://pubmed.ncbi.nlm.nih.gov/40263908/). *Perfusion*. [Review / Meta-Analysis]

• Nendumba G (2025). [PMID: 41247632](https://pubmed.ncbi.nlm.nih.gov/41247632/). *Annals of intensive care*. [Review / Meta-Analysis]

• Tang KB (2024). [PMID: 39194962](https://pubmed.ncbi.nlm.nih.gov/39194962/). *Clinical toxicology (Philadelphia, Pa.)*. [Epidemiology / Natural History]